Commercialization: Page 34
-
PharmaVoice Team/PharmaVoice
Letter from the Editor
Creating an experience What do customers want? This is a question every CEO and C-suite executive is asking themselves more and more frequently. How they respond to this question is what can set one company apart from its competitors. Among the topics explored in this month’s cover story are cust...
By Taren Grom • Feb. 1, 2017 -
PharmaVoice Team/PharmaVoice
The Creative Process
As challenging as creating a great piece of marketing is, over the years some pharma brands have still managed to nail it. According to a 2016 AdWeek CMO report, there are several examples of award-winning, but most importantly, memorable campaigns over the years that have successfully boosted br...
By Robin Robinson • Feb. 1, 2017 -
PharmaVoice Team/PharmaVoice
Smart Will Win!
The more this industry changes, the more it stays the same. The companies that apply their intelligence to winning the transactional nature of our business will ultimately succeed. Whether you study the pharmaceutical and biotech industry from the top down or the bottom up, you will find that app...
By Peter Marchesini • Feb. 1, 2017 -
PharmaVoice Team/PharmaVoice
An Outsourcing Evolution: Why Improving Yesterday's Model Addresses Tomorrow's Needs
Under the traditional model for drug delivery and commercialization, there are many opportunities for patients to slip through the cracks. In the rare disease sector specifically, therapies typically flow through a half-dozen disjointed, uncoordinated middlemen, including wholesalers, distributor...
By Danny Williams • Feb. 1, 2017 -
PharmaVoice Team/PharmaVoice
Upfront
Lilly to Expand Global Access to Healthcare Eli Lilly and Company has launched an ambitious plan to increase access to healthcare and to improve long-term health for millions of people worldwide. Through investments in people, medicines and health systems, Lilly aims to reach 30 million people i...
By PharmaVoice Team • Jan. 1, 2017 -
PharmaVoice Team/PharmaVoice
A Conversation with Dr. Cameron Durrant
In an exclusive interview with PharmaVOICE’s Editor Taren Grom, Cameron Durrant, M.D., current CEO and chairman of KaloBios, talks about taking the helm of the embattled small biotech company amid controversy, bankruptcy, and uncertainty, as well as the personal lessons learned along the way as h...
By Cameron Durrent • Jan. 1, 2017 -
PharmaVoice Team/PharmaVoice
Don't Mistake Copy for Content Marketing
More than half — 58% — of the pharma/biotech industry is spending more than $50 million in content development every year, but much of that content is not connected to a solid objective, which means money and time are being wasted. In a recent Accenture study, only 11% of pharma/biotech marketers...
By Robin Robinson • Jan. 1, 2017 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Social Media
Social Media Trends What’s hot, what’s not, and the analytics driving it all. For the first time, digital and social media ad spending — $72.09 billion — surpassed that of TV — $71.29 billion, according to a recent study from eMarketer. This shift may have marketers everywhere revisiting their st...
By PharmaVoice Team • Jan. 1, 2017 -
PharmaVoice Team/PharmaVoice
Social Media Is Pharma's Key To Reaching Millennials
Millennials? Hmmph. “I’m sick of hearing about them. They’re not driving my business, and I couldn’t care less about them." If you fall into this camp, you’re not reading the tea leaves. Today, the average age of a millennial is 26. They are the largest generation in the United States, at 75.4 mi...
By Joe Youssef • Jan. 1, 2017 -
PharmaVoice Team/PharmaVoice
Ease Your Way Into Social
As the generation marketers have labeled “millennials" mature into their role as heads of family and healthcare consumers, how can modern pharmaceutical brands begin to build a relationship with them? For a generation that has come of age as digital and social media natives, how do we engage with...
By Winnie Tan • Jan. 1, 2017 -
PharmaVoice Team/PharmaVoice
Transcending Traditional Social Media: From Awareness to Uncovering Actionable Insights
It goes without saying that social media is one of the most widely used forms of communication today. Pharmaceutical companies are trying to “crack the code" and understand how to effectively use this channel to achieve organizational initiatives while complying with rigorous industry regulation...
By Dr. Theodore Search • Jan. 1, 2017 -
PharmaVoice Team/PharmaVoice
Upfront
Industry at Large AbbVie Ireland Takes Efforts to Reduce Carbon Footprint AbbVie’s facility in Sligo, Ireland, was the first of the company’s sites to address how to save energy and reduce its carbon footprint by implementing ISO 50001 standards for improving energy management systems. The progr...
By PharmaVoice Team • Nov. 21, 2016 -
PharmaVoice Team/PharmaVoice
mHealth
Remote Patient Monitoring Device Market to Reach $1.5 Billion by 2024 Trending Now: From smart bras to inhalers, remote monitoring devices continue to gain traction. Cardiovascular Diseases, Respiratory Disorders, and Diabetes Drive Growth in Global Remote Patient Monitoring Device Market Accord...
By PharmaVoice Team • Nov. 21, 2016 -
PharmaVoice Team/PharmaVoice
Trending 2017: Triple Aim
There is a continuing push within the healthcare ecosystem toward patient-centric care, population health, and cost and value. These three areas dramatically impact the industry across myriad operational and executional channels. Triple Aim, an initiative that serves as the foundation for organiz...
By PharmaVoice Team • Nov. 21, 2016 -
PharmaVoice Team/PharmaVoice
Trending 2017: Virtual Reality
What do Pokemon Go, Zombies, Run!, and Excedrin have in common? They are all using augmented or virtual reality to motivate consumers to be more active, or in the case of Excedrin, to be more compassionate. Earlier this year, Excedrin launched the world’s first augmented reality (AR) migraine sim...
By PharmaVoice Team • Nov. 21, 2016 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: eSolutions
E-Solutions are forever changing the industry. Many of the top 10 trends identified in this issue that are expected to impact the industry in the near- and long-term are based on disruptive technologies and solutions. As Bertalan Mesko, Ph.D., “The Medical Futurist" notes, disruptive technology i...
By Taren Grom • Nov. 21, 2016 -
PharmaVoice Team/PharmaVoice
It's All Related: Veganism, EHR, and Conversational Marketing
Humans have no need for animal products; the increasing numbers of vegans in this country (and planet), is a testament to how easy it is to live a healthily fulfilling lifestyle without ever harming an animal." This quote by author Angel Finn inspired me to make a change, one my family and I have...
By Angelo Campano • Nov. 21, 2016 -
PharmaVoice Team/PharmaVoice
If A Picture Is Worth A Thousand Words, Video is Worth A Million
At the heart of every digital trend is a user behavior — video is no different. As humans, we have loved telling stories since the beginning of time. We love telling stories, and hearing them, and there is no better medium for storytelling than video. Proof Is in the Numbers: The Data Support Thi...
By Chris Cullmann • Nov. 21, 2016 -
PharmaVoice Team/PharmaVoice
Artificial Intelligence and Visual Analytics: Insight From Biomedical Literature is Now in Sight
The importance of the biomedical literature to the pharmaceutical industry cannot be overstated. Understanding the literature is a cornerstone for discovery, publication planning, competitive intelligence, identification of adverse events, compliance, and more. Despite being so essential for the ...
By Jeffrey Saffer • Nov. 21, 2016 -
PharmaVoice Team/PharmaVoice
Overcoming Dual Reimbursement Challenges With Integrated Digital Solutions
Many of us are watching with fascination and concern as payers decide to exit certain markets in 2017, based on the economics of delivering care in specific states. Meanwhile, there’s another payer trend that is just as important for manufacturers to follow closely — payer formulary adoption of p...
By Sandy Piscitello • Nov. 21, 2016 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Clinical Data in Real Time The number of clinical trials using mobile apps more than doubled, rising from 135 in 2014 to 300 in 2015, according to the IMS Health Study Patient Options Expand as Mobile Healthcare Apps Address Wellness and Chronic Disease Treatment Needs. No doubt when 2016 numbers...
By Taren Grom • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
Upfront
Industry at Large BMS Employees Cycle Coast to Coast to Raise Money for Cancer Research The first of six teams of Bristol-Myers Squibb oncology employees set out in September from Cannon Beach on the Oregon coast on the first leg of the 2016 Coast 2 Coast 4 Cancer Ride, a 21-day cycling ride that...
By PharmaVoice Team • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
mHealth
Novartis Niji System May Provide Earlier Diagnosis of Severe Allergic Asthma Trending Now: Point-of-care testing is gaining significance. Novartis has unveiled a novel in-office point-of-care diagnostic tool: the Niji System and Total IgE Test. This first-ever test delivers quantitative total Ig...
By PharmaVoice Team • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
Pharma Trax
High-value Specialty Medicines are Driving Growth in the Generics Market Trending now: Emerging markets are the next big opportunity after the United States. Increased life expectancy, a growing older-population cohort, and the higher incidence of chronic lifestyle-related diseases are encouragi...
By PharmaVoice Team • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
Medidata Introduces Payment Technology for Clinical Trial Sites Trending Now: The market’s first end-to-end cloud-based reimbursement tool uses clinical trial data to calculate costs and disburse payment to investigative sites in real time. Medidata has launched Medidata Payments. A new compone...
By PharmaVoice Team • Oct. 1, 2016
Previous
